GE Healthcare Life Sciences


See what others don’t The BiacoreTM 4000 system is designed for large-scale


parallel analysis and helps you achieve deeper insights into the world of molecular interaction.


• Validate hits quickly by analyzing hundreds of binding events.


• Optimize leads based on high quality affi nity, kinetics and specifi city data.


• Advance the most promising candidate with confi dence.


When late-stage failures can cost over $1 billion, that’s something to look at. To learn more, visit: www.gelifesciences.com/drugdiscoverysuite


GE, imagination at work and GE monogram are trademarks of General Electric Company.


© 2011 General Electric Company – All rights reserved. First published Oct. 2011


GE Healthcare Bio-Sciences AB, Björkgatan 30, SE-751 84 Uppsala, Sweden


Biacore 4000 A component of DRUG DISCOVERY SUITE


FTATM DMPK CARDS CYTIVATM CELL MODELS MICROCALTM SYSTEMS IN CELL ANALYZERS BIACORE SYSTEMS


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78  |  Page 79  |  Page 80